Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2025
Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder CancerValentina Tateo, Joep J de Jong, Antonio Cigliola, et al.
Journal of Translational Medicine|August 16, 2022
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIsMarzia Del Re, Stefania Crucitta, Federico Paolieri, et al.
Vaccines|June 24, 2022
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective AnalysisAmedeo Nuzzo, Simona Manacorda, Enrico Sammarco, et al.
Clinical Genitourinary Cancer|May 12, 2024
Optimizing the Use of Next-Generation Sequencing Assays in Patients With Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat PanelValentina Tateo, Antonio Cigliola, Chiara Mercinelli, et al.
JCO Precision Oncology|August 16, 2024
Urachal and Nonurachal Adenocarcinomas of the Urinary Bladder: A Comprehensive Genomic Profiling StudyAntonio Cigliola, Alina Basnet, Joseph M Jacob, et al.
Expert Review of Anticancer Therapy|June 30, 2026
Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicineChiara Mercinelli, Fabrizio Di Costanzo, Christoph Oing, et al.
The Oncologist|March 23, 2026
Homologous Recombination Deficiency and Genomic Alterations in Advanced Prostate Cancer: Insights for Precision TherapyChiara Mercinelli, Dean Pavlick, Neeraj Agarwal, et al.
European Urology|February 3, 2026
Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder CancerValentina Tateo, Giuseppe Basile, Patrizia Giannatempo, et al.
European Urology Oncology|January 6, 2024
Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder CancerRoger Li, Luigi Nocera, Kyle M Rose, et al.
European Urology Oncology|May 29, 2026
AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical CystectomyAndrea Necchi, Giorgio Brembilla, Karissa Whiting, et al.
Pageof 5